By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login

Jinling Pharmaceutical Company Limited (000919.SZ)

SHZ Currency in CNY
¥7.11
-¥0.01
-0.14%
Last Update: 29 Aug 2025, 07:04
¥4.42B
Market Cap
42.68
P/E Ratio (TTM)
1.41%
Forward Dividend Yield
¥5.55 - ¥7.85
52 Week Range

000919.SZ Stock Price Chart

Explore Jinling Pharmaceutical Company Limited interactive price chart. Choose custom timeframes to analyze 000919.SZ price movements and trends.

000919.SZ Company Profile

Discover essential business fundamentals and corporate details for Jinling Pharmaceutical Company Limited (000919.SZ) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

18 Nov 1999

Employees

5.79K

CEO

Hai Chen

Description

Jinling Pharmaceutical Company Limited manufactures and sells pharmaceutical products in China. The company offers Mailuoning injection for the treatment of thrombo-occlusive vasculitis, arteriosclerotic occlusive disease, cerebral thrombosis and sequelae, multiple arteritis, acute arterial embolism of the limbs, diabetic gangrene, venous thrombosis, thrombophlebitis, etc.; ferrous succinate tablets for the prevention and treatment of iron deficiency anemia; and lentinan injection for treatment of malignant tumors. It also provides medical health care services. Jinling Pharmaceutical Company Limited is based in Nanjing, China.

000919.SZ Financial Timeline

Browse a chronological timeline of Jinling Pharmaceutical Company Limited corporate events including earnings releases, dividend announcements, and stock splits.

Dividend declared on 8 Jul 2025

A dividend of ¥0.10 per share was announced, adjusted to ¥0.10. The dividend was paid on 8 Jul 2025.

Earnings released on 21 May 2025

EPS came in at -¥0.05 , while revenue for the quarter reached ¥1.06B .

Earnings released on 31 Mar 2025

EPS came in at ¥0.04 , while revenue for the quarter reached ¥810.01M .

Earnings released on 29 Sept 2024

EPS came in at ¥0.03 , while revenue for the quarter reached ¥709.29M .

Earnings released on 30 Jun 2024

EPS came in at ¥0.01 , while revenue for the quarter reached ¥758.74M .

Dividend declared on 31 May 2024

A dividend of ¥0.10 per share was announced, adjusted to ¥0.10. The dividend was paid on 31 May 2024.

Earnings released on 21 May 2024

EPS came in at ¥0.08 , while revenue for the quarter reached ¥746.53M .

Earnings released on 12 Mar 2024

EPS came in at ¥0.00 , while revenue for the quarter reached ¥681.49M .

Earnings released on 30 Sept 2023

EPS came in at ¥0.04 , while revenue for the quarter reached ¥662.85M .

Dividend declared on 14 Jul 2023

A dividend of ¥0.10 per share was announced, adjusted to ¥0.10. The dividend was paid on 14 Jul 2023.

Earnings released on 30 Jun 2023

EPS came in at ¥0.07 , while revenue for the quarter reached ¥732.86M .

Earnings released on 31 Mar 2023

EPS came in at ¥0.09 , while revenue for the quarter reached ¥708.53M .

Earnings released on 1 Jan 2023

EPS came in at ¥0.03 , while revenue for the quarter reached ¥617.11M .

Earnings released on 30 Sept 2022

EPS came in at ¥0.07 , while revenue for the quarter reached ¥701.68M .

Dividend declared on 11 Aug 2022

A dividend of ¥0.10 per share was announced, adjusted to ¥0.10. The dividend was paid on 11 Aug 2022.

Earnings released on 30 Jun 2022

EPS came in at ¥0.04 , while revenue for the quarter reached ¥659.16M .

Earnings released on 31 Mar 2022

EPS came in at ¥0.08 , while revenue for the quarter reached ¥693.02M .

Earnings released on 31 Dec 2021

EPS came in at ¥0.05 , while revenue for the quarter reached ¥697.74M .

Earnings released on 30 Sept 2021

EPS came in at ¥0.04 , while revenue for the quarter reached ¥688.79M .

Dividend declared on 12 Aug 2021

A dividend of ¥0.10 per share was announced, adjusted to ¥0.10. The dividend was paid on 12 Aug 2021.

Earnings released on 30 Jun 2021

EPS came in at ¥0.08 , while revenue for the quarter reached ¥720.62M .

Earnings released on 27 Apr 2021

EPS came in at -¥0.02 , while revenue for the quarter reached ¥685.30M .

Earnings released on 31 Mar 2021

EPS came in at ¥0.07 , while revenue for the quarter reached ¥701.60M .

Earnings released on 30 Sept 2020

EPS came in at ¥0.11 , while revenue for the quarter reached ¥675.24M .

000919.SZ Stock Performance

Access detailed 000919.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run